dc.relation.reference | 1. Metzger BE, Coustan DR: Proceedings of the Fourth International Workshop Conference on Gestational Diabertes Mellitus. Diabetes Care 21 1998 (suppl.2): B1-B167
2. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM. Diabetes, 1991, 40(suppl2):18-24.
3. Mulfold MI, Jovanovic-Peterson L and Peterson CM: Alternative therapies for the management of gestational diabetes. Clinic in Perinatology 1993;20:219.
4. Diabetes Care, Volume 25, Supplement 1, January 2002, S94-S96.
5. Kjos SL, Peters RK, Xiang A, et al. Predicting future diabetes in Latino women with gestational diabetes. Diabetes, 1995;44:586-591.
6. Martin BC, Warram JM, Krolewskl AS, et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: result of a 25-year follow-up study. Lancet, 1992, 340:925-929.
7. Weeks JW, Major CA, Morgan MA. Gestational diabetes: dose the presence of risk factor influence perinatal outcome? Am J Obstet Gynecol 1994;171:1003-1007.
8. Blank A, Grave GD, Metzger BE. Effect of gestational diabetes on perinatal morbidity reassessed report of the International Workshop on adverse perinatal outcomes of gestational diabetes mellitus, December 3-4, 1992. Diabetes Care 1995;18:127-129.
9. Cousins LM. Pregnancy complication among diabetes women: review 1965-85. Obstet Gynecol Surv 1987;42:140-143.
10.Cousins L, Baxi L, et al. Screening recommendations for gestational diabetes mellitus. Am J Obstet Gynecol 1991;165:493-496.
11.Langer O, Levy J,et al. Glycaemic control in gestational diabetes mellitus- how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;161:646-653
12.O’sullivan JB, Mahan CM, Charles D,et al: Screening criteria for high risk gestational diabetes patients. Am J Obstet Gynecol 1973;116:895-900.
13. Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773.
14. American College of Obstetricians and Gynecologists. Management of diabetes mellitus in pregnancy. ACOG Technical Bull 1986;92:1-2.
15. Orion A, James A, Morrison, et al. Lowering the threshold for the diagnosis of gestational diabetes. Am J Obstet Gynecol 1996;175:961-5.
16.O’Sullivan JB and Mahan CM: Criteria for OGTT in pregnancy. Diabetes 1964; 13:278-285.
17.O’Sullivan JB , Mahan CM, Charles D & Dandrow RV: GDM and perinatal mortality rate. Am J Obstet Gynecol 1973(a);116:901-904.
18.Carpenter MW and Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773.
19.Anonymous: Second International Workshop: Conference on gestational diabetes mellitus. Summary and recommendations. Diabetes 1985; 34(suppl.2):106-110.
20.Diane K, Richard G, et al. Adverse effect of screening for gestational diabetes: A prospective cohort study in Toronto, Canada. J. of Medical Screening 1997;4:128-132.
21.Hadden DR: Geographic, ethnic, and racial variation in the incidence of gestational diabetes mellitus. Diabaetes 1985;34(suppl. 2):8-12.
22.Lavin JP et al: Clinical experience with a screening program for gestational diabetes. Am J Obstet Gynecol 1981;141:491.
23.Al-Shawaf T, Moghraby S, Akiel A: Dose impaired glucose tolerance imply a risk in pregnancy? Br J Obstet Gynecol 1988;95:1036-1041.
24. Al-Shawaf T, Akiel A, Moghraby S: Gestational diabetes mellitus and impaired glucose tolerance of pregnancy in Riyadh. Br J Obstet Gynecol 1988;95:84-90.
25.Diana R, Danilenko-Dixon, et al. Universal versus selective gestational diabetes screening: Application of 1997 American Diabetes Association recommemdations. Am J Obstet Gynecol 1999;181:798-802.
26.C. David Naylor, et al. Selective screening for gestational diabetes mellitus. N Engl J Med 1997;337:1591-6.
27.Kaufmann RC, McBride P, Amankwah KS, Huffman DG.. The effect of minor degree of glucose intolerance on the incidence of neonatal macrosomia. Obstet Gynecol 1992;80:97-101.
28.Berkus MD, Langer O. Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol 1993;81:344-348
29.Sermer M, Naylor CD, Gare DJ, Kenshole AB, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: the Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146-156..
30.Cousin L. Obsteric complication. In: EA Reece, DR Coustan, eds. Diabetes mellitus in pregnancy. 2nd ed. New York: Churchill Livingstone, 1995: 275: 1165-1170 (Level II-2)
31.Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G. Relation of glucose tolerance to complications of pregnancy in nondiabetes women. N Engl J Med 1986;315: 989-992 (Level II-3)
32.Solomen CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278: 1078-1083 (Level II-3).
33.Francesco C, Narciso CS, et al. Screening for gestational diabetes in Sicily.J Reprod Med. 1999 Oct;44(10):875-8.
34.Matteo B, Maria LG, Arturo M, et al. Which cutoff level should be used in screening for glucose intolerance in pregnancy? Am J Obstet Gynecol 1998;179:179-85.
35.Christa B, et al. Effect of selective screening for gestational diabetes.Diabetes Care. 1999 Mar,22(3):418-21
36. Marshall W, Carpenter and Coustan. Criteria for screening tests for gestational diabetes . Am J Obstet Gynecol .1982;144:768,
37. M.E. Griffin, et al.Universal vs. risk factor-based screening for gestational diabetes mellitus:detection rate, gestation at diagnosis and outcome. 2000 British Diabetic Association. Diabetic Medicine, 17, 26-32
38.Jose J, Jimenez-Moleon, et al. Predictive value of a screen for gestational diabetes mellitus: influence of associated risk factors. Acta Obstet Gynecol Scand 2000 Nov;79(11):991-8 | en |